Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Frontzek

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Journal of the Neurological Sciences|December 15, 2023
Neurologic involvement in cystinosis: Focus on brain lesions and new evidence of four-repeat (4R-) Tau immunoreactivityTommaso Nicoletti, Andrea Bink, Birgit Helmchen, et al.
Plos Pathogens|October 2, 2018
A bispecific immunotweezer prevents soluble PrP oligomers and abolishes prion toxicityMarco Bardelli, Karl Frontzek, Luca Simonelli, et al.
Brain Communications|November 29, 2023
The Brainbox<i>-</i>a tool to facilitate correlation of brain magnetic resonance imaging features to histopathologyWolfgang Faigle, Marco Piccirelli, Tibor Hortobágyi, et al.
EMBO Molecular Medicine|August 11, 2020
Protective anti-prion antibodies in human immunoglobulin repertoiresAssunta Senatore, Karl Frontzek, Marc Emmenegger, et al.
Neuropathology and Applied Neurobiology|November 29, 2020
Intracerebral endotheliitis and microbleeds are neuropathological features of COVID-19Daniel Kirschenbaum, Lukas L Imbach, Elisabeth J Rushing, et al.
Stroke|October 15, 2020
Large and Small Cerebral Vessel Involvement in Severe COVID-19: Detailed Clinical Workup of a Case SeriesEmanuela Keller, Giovanna Brandi, Sebastian Winklhofer, et al.
Neurology|February 27, 2020
Autoantibodies against the prion protein in individuals with <i>PRNP</i> mutationsKarl Frontzek, Manfredi Carta, Marco Losa, et al.
Nature Structural & Molecular Biology|August 10, 2022
A conformational switch controlling the toxicity of the prion proteinKarl Frontzek, Marco Bardelli, Assunta Senatore, et al.
Nature|February 14, 2024
A model of human neural networks reveals NPTX2 pathology in ALS and FTLDMarian Hruska-Plochan, Vera I Wiersma, Katharina M Betz, et al.
Science Advances|November 24, 2021
Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathiesLuise Linsenmeier, Behnam Mohammadi, Mohsin Shafiq, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of the Neurological Sciences|December 15, 2023
Neurologic involvement in cystinosis: Focus on brain lesions and new evidence of four-repeat (4R-) Tau immunoreactivityTommaso Nicoletti, Andrea Bink, Birgit Helmchen, et al.
Plos Pathogens|October 2, 2018
A bispecific immunotweezer prevents soluble PrP oligomers and abolishes prion toxicityMarco Bardelli, Karl Frontzek, Luca Simonelli, et al.
Brain Communications|November 29, 2023
The Brainbox<i>-</i>a tool to facilitate correlation of brain magnetic resonance imaging features to histopathologyWolfgang Faigle, Marco Piccirelli, Tibor Hortobágyi, et al.
EMBO Molecular Medicine|August 11, 2020
Protective anti-prion antibodies in human immunoglobulin repertoiresAssunta Senatore, Karl Frontzek, Marc Emmenegger, et al.
Neuropathology and Applied Neurobiology|November 29, 2020
Intracerebral endotheliitis and microbleeds are neuropathological features of COVID-19Daniel Kirschenbaum, Lukas L Imbach, Elisabeth J Rushing, et al.
Stroke|October 15, 2020
Large and Small Cerebral Vessel Involvement in Severe COVID-19: Detailed Clinical Workup of a Case SeriesEmanuela Keller, Giovanna Brandi, Sebastian Winklhofer, et al.
Neurology|February 27, 2020
Autoantibodies against the prion protein in individuals with <i>PRNP</i> mutationsKarl Frontzek, Manfredi Carta, Marco Losa, et al.
Nature Structural & Molecular Biology|August 10, 2022
A conformational switch controlling the toxicity of the prion proteinKarl Frontzek, Marco Bardelli, Assunta Senatore, et al.
Nature|February 14, 2024
A model of human neural networks reveals NPTX2 pathology in ALS and FTLDMarian Hruska-Plochan, Vera I Wiersma, Katharina M Betz, et al.
Science Advances|November 24, 2021
Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathiesLuise Linsenmeier, Behnam Mohammadi, Mohsin Shafiq, et al.
Pageof 4